Plasma Nor-/Metanephrines

Enzymeimmunoassay for the quantitative determination of unconjugated (free) Normetanephrine and Metanephrine in plasma

Clinical Fields: Endocrinology, Oncology
Diseases: Pheochromocytoma

Catalog No Size
Product Catalog No: EA612/192 Pack Size: 96 wells

Pack Size:
Pack Size:
Pack Size:
Pack Size:

Category:
Test Principle

Normetanephrine and metanephrine are physiologically formed from the catecholamines noradrenaline and adrenaline by the enzyme catechol-Omethyltransferase (COMT). Increased levels of normetanephrine and metanephrine can be found in patients suffering from pheochromocytoma, ganglioneuroma and other neurogenic tumors.

The assay kit provides materials for the quantitative measurement of free normetanephrine and metanephrine in human EDTA plasma. Normetanephrine and metanephrine are separated from plasma proteins through addition of precipitation reagents and then are quantitatively acylated to their N-acylderivates.

The competitive Nor-/ Metanephrine ELISA kit uses the microtitre plate format. Metanephrine and normetanephrine, respectively, are bound to the solid phase of the microtiter plate. Acylated nor-/metanephrines from the sample and solid phase bound nor-/metanephrines compete for a fixed number of antiserum binding sites. When the system is in equilibrium, free antigen and free antigenantiserum complexes are removed by washing. The antibody bound to the solid phase nor-/metanephrines is detected by anti-rabbit IgG/peroxidase. The substrate TMB/peroxidase reaction is monitored at 450 nm. The amount of antibody bound to the solid phase nor-/metanephrines is inversely proportional to the nor-/metanephrines concentration of the sample.

Order Enquiry

    Order Enquiry Form

    References
    • Unger, N.; Pitt, C.; Petersenn, S.; et al. (2006): Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass European Journal of Endocrinology 154 409–417
    • Eisenhofer, G.; Walther, M.; Keiser, H.; et al. (2000): Plasma metanephrines: a novel and costeffective test for pheochromocytoma Brazilian Journal of Medical and Biological Research 33: 1157-1169
    • Bravo, E. (2004): Pheochromocytoma: Current Perspectives in the Pathogenesis, Diagnosis, and Management Arq Bras Endocrinol Metab 48/5:746-750
    • Candito, M.; Billaud, E.; Chauffert, M.; et al. (2002): Biochemical diagnosis of pheochromocytoma and neuroblastomas Ann Biol Clin (Paris). 2002 Jan-Feb;60(1):15-36.
    • Lenders, J.; Pacak, K.; McClellan, M.; et al. (2002):: Biochemical Diagnosis of Pheochromocytoma Which Test Is Best? Jama, March 20, 2002-Vol 287, No. 11
    • Eisenhofer, G.; Keiser, H.; Friberg, P.; et al. (1998): Plasma Metanephrines Are Markers of Pheochromocytoma Produced by Catechol-O-MethyltransferaseWithin Tumors Journal of Clinical Endocrinology and Metabolism Vol. 83, No. 6
    • Lenders, J.; Keiser, H.; Goldstein, D.; et al. (1995): Plasma Metanephrines in the Diagnosis of Pheochromocytoma Annals of Internal Medicine • Volume 123 • Number 2
    Enquiry